Hvis væksten påvirkes, bør behandlingen revurderes for eventuelt at reduceres til laveste effektive dosis, hvor symptomerne stadig er under kontrol.
If growth is slowed, therapy should be reviewed with the aim of reducing the dose of nasal corticosteroid if possible, to the lowest dose at which effective control of symptoms is maintained.